Study Objective: To investigate whether hysteroscopic proximal tubal occlusion with Essure microinserts (Conceptus Inc.; Bayer, AG, North Rhine-Westphalia, Germany) can improve pregnancy rates in patients with hydrosalpinges who had failed in vitro fertilization (IVF) treatment.
Design: A prospective cohort study.
Introduction: Essure hysteroscopic sterilization is a minimally invasive, outpatient approach to female sterilization, which avoids the possible complications of laparoscopic sterilization. This procedure has been available since 2003 in both Europe and North America. We present our experience of the first 12 cases of the procedure performed in Israel.
View Article and Find Full Text PDF